Voyager Therapeutics, Inc. Common Stock (NASDAQ: VYGR) last traded at $2.27, down 7.35% on the session. The quote above updates while this page is open; the figures below are drawn from Voyager Therapeutics, Inc. Common Stock’s own filings and are restated only when a new one is published.
Voyager Therapeutics, Inc. Common Stock trades on NASDAQ under the ticker VYGR. Its market capitalisation is $139.87 million.
Valuation measures for Voyager Therapeutics, Inc. Common Stock, derived from the latest quote and its most recent SEC filing.
| Market cap | $139.87M |
|---|---|
| Enterprise value | $147.48M |
| Price / sales | 4.06 |
| Price / book | 0.91 |
| Beta | 1.22 |
Trailing-twelve-month figures tagged in Voyager Therapeutics, Inc. Common Stock's XBRL filings with the SEC.
| Revenue (TTM) | $34.46M |
|---|---|
| Net income (TTM) | -$107.73M |
| EPS (TTM) | -$1.81 |
| Operating margin | -340.08% |
| Return on equity | -69.78% |
| Cash | $35.77M |
Range and volume for VYGR over the past 52 weeks.
| 52-week high | $5.55 |
|---|---|
| 52-week low | $2.25 |
| Volume | 966.9K |
| Average volume | 578.9K |
| Previous close | $2.45 |
Invest a chosen dollar amount in Voyager Therapeutics, Inc. Common Stock with fractional shares.
Start investingCreate an account
Investing involves risk, including possible loss of principal. Nothing here is investment advice or a recommendation to buy or sell VYGR.
A dash means FurlPay does not have that figure, not that it is zero. Nothing on this page is investment advice or a recommendation to buy or sell any security. Figures are provided for information only and may be delayed or restated.